Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23,662 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quantitative flow ratio-guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial.
Song L, Tu S, Sun Z, Wang Y, Ding D, Guan C, Xie L, Escaned J, Fearon WF, Kirtane AJ, Serruys PW, Wijns W, Windecker S, Leon MB, Stone GW, Qiao S, Xu B; FAVOR III China Investigators. Song L, et al. Among authors: sun z. Am Heart J. 2020 May;223:72-80. doi: 10.1016/j.ahj.2020.02.015. Epub 2020 Feb 24. Am Heart J. 2020. PMID: 32179258
In vivo comparison of arterial lumen dimensions assessed by co-registered three-dimensional (3D) quantitative coronary angiography, intravascular ultrasound and optical coherence tomography.
Tu S, Xu L, Ligthart J, Xu B, Witberg K, Sun Z, Koning G, Reiber JH, Regar E. Tu S, et al. Among authors: sun z. Int J Cardiovasc Imaging. 2012 Aug;28(6):1315-27. doi: 10.1007/s10554-012-0016-6. Epub 2012 Jan 20. Int J Cardiovasc Imaging. 2012. PMID: 22261998 Free PMC article.
Optical coherence tomography assessment of a PLGA-polymer with electro-grafting base layer versus a PLA-polymer sirolimus-eluting stent at three-month follow-up: the BuMA-OCT randomised trial.
Qian J, Zhang YJ, Xu B, Yang YJ, Yan HB, Sun ZW, Zhao YL, Tang YD, Gao Z, Chen J, Cui JG, Mintz GS, Gao RL. Qian J, et al. Among authors: sun zw. EuroIntervention. 2014 Nov;10(7):806-14. doi: 10.4244/EIJY14M07_17. EuroIntervention. 2014. PMID: 25033105 Free article. Clinical Trial.
Comparison of long-term in-stent vascular response between abluminal groove-filled biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent: 3-year OCT follow-up from the TARGET I trial.
Xu B, Zhang YJ, Sun ZW, Qiao SB, Chen SL, Zhang RY, Pan DR, Pang S, Zhang Q, Xu L, Yang YJ, Leon MB, Gao RL. Xu B, et al. Int J Cardiovasc Imaging. 2015 Dec;31(8):1489-96. doi: 10.1007/s10554-015-0721-z. Epub 2015 Jul 26. Int J Cardiovasc Imaging. 2015. PMID: 26208685 Clinical Trial.
Comparison of two biodegradable-polymer-based sirolimus-eluting stents with varying elution and absorption kinetics in patients with acute myocardial infarction: A subgroup analysis of the PANDA III trial.
Guan C, Xu B, Qiao S, Qin L, Li Y, Li Z, Guo Y, Sun Z, Song L, Gao R; PANDA III Investigators. Guan C, et al. Among authors: sun z. Catheter Cardiovasc Interv. 2017 Mar;89(S1):520-527. doi: 10.1002/ccd.26918. Epub 2017 Jan 21. Catheter Cardiovasc Interv. 2017. PMID: 28109057 Clinical Trial.
A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting Stents.
Han Y, Xu B, Fu G, Wang X, Xu K, Jin C, Tao L, Li L, Hou Y, Su X, Fang Q, Chen L, Liu H, Wang B, Yuan Z, Gao C, Zhou S, Sun Z, Zhao Y, Guan C, Stone GW; NeoVas Randomized Controlled Trial Investigators. Han Y, et al. Among authors: sun z. JACC Cardiovasc Interv. 2018 Feb 12;11(3):260-272. doi: 10.1016/j.jcin.2017.09.037. JACC Cardiovasc Interv. 2018. PMID: 29413240 Free article. Clinical Trial.
23,662 results
You have reached the last available page of results. Please see the User Guide for more information.